Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bolni Nagalo

Concepts (204)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
35
4.130
 Why?
Hepatitis B
8
2023
27
2.230
 Why?
Oncolytic Virotherapy
3
2022
18
1.780
 Why?
HIV Infections
11
2021
394
1.620
 Why?
Hepatitis B Surface Antigens
4
2018
10
1.600
 Why?
Syphilis
7
2019
25
1.400
 Why?
Carcinoma, Hepatocellular
4
2023
203
1.210
 Why?
Hepatitis C
5
2021
94
1.190
 Why?
Blood Transfusion
3
2021
138
1.180
 Why?
Liver Neoplasms
4
2023
352
1.090
 Why?
Seroepidemiologic Studies
10
2021
50
0.960
 Why?
Burkina Faso
16
2023
16
0.940
 Why?
Vesicular Stomatitis
1
2022
1
0.880
 Why?
Enzyme-Linked Immunosorbent Assay
4
2018
314
0.780
 Why?
Biliary Tract Neoplasms
4
2022
8
0.780
 Why?
HIV Antibodies
1
2018
18
0.680
 Why?
Blood-Borne Pathogens
1
2018
8
0.670
 Why?
HIV-1
4
2018
72
0.610
 Why?
Gabon
4
2019
5
0.550
 Why?
Mass Screening
1
2018
370
0.520
 Why?
Rural Population
1
2018
598
0.470
 Why?
Young Adult
11
2021
4318
0.460
 Why?
HIV Seroprevalence
2
2014
4
0.440
 Why?
Vesiculovirus
2
2022
5
0.440
 Why?
Skin Neoplasms
3
2024
532
0.440
 Why?
Cholangiocarcinoma
2
2022
30
0.420
 Why?
Bile Duct Neoplasms
2
2022
33
0.420
 Why?
Humans
35
2024
54391
0.410
 Why?
Antibodies, Viral
1
2011
124
0.400
 Why?
Adolescent
10
2021
6900
0.390
 Why?
Plasma
1
2011
52
0.390
 Why?
Communicable Diseases
1
2011
58
0.390
 Why?
Adult
16
2021
14207
0.380
 Why?
Melanoma
2
2024
313
0.330
 Why?
Prevalence
6
2018
1025
0.300
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
1060
0.280
 Why?
Female
17
2021
28471
0.280
 Why?
Middle Aged
12
2020
13082
0.280
 Why?
Sensitivity and Specificity
2
2018
922
0.270
 Why?
Male
14
2021
27347
0.270
 Why?
Hepacivirus
2
2018
127
0.260
 Why?
Molecular Docking Simulation
2
2023
83
0.250
 Why?
Cell Proliferation
4
2024
1097
0.250
 Why?
Monophenol Monooxygenase
1
2023
4
0.240
 Why?
Carcinoma, Pancreatic Ductal
1
2024
35
0.240
 Why?
Cell Line, Tumor
3
2024
1551
0.230
 Why?
Anti-HIV Agents
2
2014
43
0.230
 Why?
Incidence
2
2021
1083
0.230
 Why?
Drug Synergism
2
2021
171
0.230
 Why?
Antineoplastic Agents
2
2024
1300
0.230
 Why?
Hepatitis B virus
2
2023
24
0.220
 Why?
Vesicular stomatitis Indiana virus
1
2022
4
0.220
 Why?
Dermatitis
1
2023
42
0.220
 Why?
Psoriasis
1
2023
43
0.210
 Why?
Animals
6
2023
14409
0.210
 Why?
Antioxidants
2
2023
297
0.210
 Why?
Treponema pallidum
2
2018
10
0.200
 Why?
Flavonols
1
2020
4
0.200
 Why?
Students, Medical
1
2023
178
0.200
 Why?
Pancreatic Neoplasms
1
2024
234
0.190
 Why?
Viral Proteins
1
2022
158
0.190
 Why?
Cymbopogon
1
2020
1
0.190
 Why?
Oils, Volatile
1
2020
10
0.190
 Why?
Risk Factors
4
2020
3937
0.190
 Why?
Receptors, KIR
1
2019
15
0.180
 Why?
Protein Kinase Inhibitors
1
2021
216
0.180
 Why?
Immunotherapy
2
2021
264
0.180
 Why?
Disease Models, Animal
2
2023
1647
0.180
 Why?
Sequence Deletion
1
2020
99
0.180
 Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.180
 Why?
Polymorphism, Genetic
1
2020
193
0.170
 Why?
Glutathione Transferase
1
2020
178
0.170
 Why?
Mice
4
2023
6428
0.170
 Why?
Virology
1
2018
9
0.170
 Why?
Retrospective Studies
6
2022
6459
0.170
 Why?
HIV
1
2018
26
0.170
 Why?
Anti-Inflammatory Agents
1
2020
175
0.170
 Why?
Aged
6
2022
10060
0.160
 Why?
Molecular Structure
3
2024
319
0.160
 Why?
Immunotherapy, Adoptive
1
2018
134
0.150
 Why?
Blood Pressure
1
2019
587
0.140
 Why?
Odds Ratio
1
2018
600
0.140
 Why?
Polymorphism, Single Nucleotide
1
2019
552
0.140
 Why?
T-Lymphocytes
1
2018
374
0.140
 Why?
Cross-Sectional Studies
2
2018
1696
0.130
 Why?
Polymerase Chain Reaction
2
2014
531
0.130
 Why?
HIV-2
1
2014
1
0.130
 Why?
Hospitals, Military
1
2014
7
0.130
 Why?
Cisplatin
3
2022
351
0.130
 Why?
Syphilis Serodiagnosis
1
2014
2
0.130
 Why?
Drug Monitoring
1
2014
85
0.120
 Why?
RNA, Viral
2
2014
141
0.120
 Why?
Peritonitis
1
2014
33
0.120
 Why?
Community-Acquired Infections
1
2014
42
0.120
 Why?
Time Factors
2
2018
3210
0.120
 Why?
Viremia
1
2014
25
0.120
 Why?
Immunocompromised Host
1
2014
130
0.120
 Why?
Genotype
3
2023
600
0.120
 Why?
Antibodies, Monoclonal
1
2018
564
0.120
 Why?
Genetic Predisposition to Disease
3
2023
570
0.110
 Why?
Meningitis, Bacterial
1
2013
9
0.110
 Why?
Neoplasms
1
2023
1322
0.110
 Why?
Infectious Disease Transmission, Vertical
1
2012
16
0.110
 Why?
Rubella
1
2012
3
0.110
 Why?
Toxoplasmosis
1
2012
15
0.110
 Why?
Antibodies, Protozoan
1
2012
12
0.110
 Why?
Antiretroviral Therapy, Highly Active
1
2012
40
0.110
 Why?
Gene Frequency
2
2023
120
0.110
 Why?
Bile Ducts, Intrahepatic
2
2022
17
0.110
 Why?
Real-Time Polymerase Chain Reaction
1
2013
206
0.110
 Why?
Drug Screening Assays, Antitumor
2
2024
142
0.100
 Why?
Case-Control Studies
3
2020
1229
0.100
 Why?
Bacteria
1
2014
258
0.100
 Why?
Pilot Projects
2
2013
807
0.100
 Why?
Pregnancy Complications, Infectious
1
2012
75
0.100
 Why?
TOR Serine-Threonine Kinases
2
2023
85
0.100
 Why?
Apoptosis
3
2024
1302
0.100
 Why?
Deoxycytidine
2
2021
28
0.100
 Why?
Tumor Microenvironment
2
2024
210
0.100
 Why?
Structure-Activity Relationship
2
2024
423
0.100
 Why?
Hospitals, Teaching
1
2011
58
0.100
 Why?
Xenograft Model Antitumor Assays
2
2021
219
0.090
 Why?
Autophagy
2
2023
202
0.090
 Why?
Programmed Cell Death 1 Receptor
2
2021
40
0.090
 Why?
Tumor Cells, Cultured
2
2020
477
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
674
0.090
 Why?
Prospective Studies
2
2012
2606
0.080
 Why?
Anti-Bacterial Agents
1
2014
825
0.080
 Why?
rho-Associated Kinases
1
2024
20
0.060
 Why?
Blood Banks
2
2014
20
0.060
 Why?
Hedgehog Proteins
1
2024
33
0.060
 Why?
Azoles
1
2023
28
0.060
 Why?
Immunomodulation
1
2024
42
0.060
 Why?
HLA-DRB1 Chains
1
2023
8
0.060
 Why?
Research
1
2023
117
0.060
 Why?
HLA Antigens
1
2023
56
0.060
 Why?
Pyrazoles
1
2023
110
0.060
 Why?
Interleukin-17
1
2023
38
0.060
 Why?
Medical Oncology
1
2023
110
0.050
 Why?
Platinum
1
2022
13
0.050
 Why?
Sirolimus
1
2023
65
0.050
 Why?
Computer Simulation
1
2023
332
0.050
 Why?
Clone Cells
1
2022
89
0.050
 Why?
Alleles
1
2023
277
0.050
 Why?
Cyclin-Dependent Kinase 6
1
2021
3
0.050
 Why?
Cyclin-Dependent Kinase 4
1
2021
15
0.050
 Why?
Proto-Oncogene Proteins c-akt
1
2023
176
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2023
153
0.050
 Why?
Program Evaluation
1
2023
379
0.050
 Why?
Pregnancy
3
2014
2639
0.050
 Why?
Cyclin-Dependent Kinase 2
1
2020
28
0.050
 Why?
Enzyme Inhibitors
1
2023
446
0.050
 Why?
Proto-Oncogene Proteins c-kit
1
2020
35
0.050
 Why?
Liver Cirrhosis
1
2023
218
0.050
 Why?
Cytidine Monophosphate
1
2020
4
0.050
 Why?
Flame Ionization
1
2020
2
0.050
 Why?
Curriculum
1
2023
434
0.050
 Why?
Medicine, Traditional
1
2020
18
0.050
 Why?
Mice, Inbred NOD
1
2020
99
0.050
 Why?
Plant Leaves
1
2020
49
0.050
 Why?
Gas Chromatography-Mass Spectrometry
1
2020
70
0.050
 Why?
Mice, SCID
1
2020
196
0.050
 Why?
Aldehydes
1
2020
97
0.040
 Why?
Genomics
1
2021
313
0.040
 Why?
Cytokines
1
2023
677
0.040
 Why?
DNA, Viral
1
2019
143
0.040
 Why?
Sesquiterpenes
1
2020
91
0.040
 Why?
Lipids
1
2020
178
0.040
 Why?
CTLA-4 Antigen
1
2018
29
0.040
 Why?
Cell Survival
1
2020
657
0.040
 Why?
Genetic Association Studies
1
2019
136
0.040
 Why?
Cohort Studies
1
2023
1546
0.040
 Why?
Immunohistochemistry
1
2021
1090
0.040
 Why?
Inflammation
1
2023
678
0.040
 Why?
Alcohol Drinking
1
2020
259
0.040
 Why?
Neoplasm Recurrence, Local
1
2021
645
0.040
 Why?
Dose-Response Relationship, Drug
1
2020
1476
0.040
 Why?
Body Mass Index
1
2020
712
0.040
 Why?
Signal Transduction
1
2024
1752
0.040
 Why?
Phenotype
1
2019
819
0.030
 Why?
Smoking
1
2020
552
0.030
 Why?
CD4 Lymphocyte Count
1
2014
35
0.030
 Why?
Opportunistic Infections
1
2014
58
0.030
 Why?
Aged, 80 and over
1
2022
3431
0.030
 Why?
Risk Assessment
1
2019
1362
0.030
 Why?
Reagent Kits, Diagnostic
1
2014
22
0.030
 Why?
Hepatitis C Antibodies
1
2014
21
0.030
 Why?
Genotyping Techniques
1
2014
26
0.030
 Why?
Donor Selection
1
2014
13
0.030
 Why?
Drug Resistance, Bacterial
1
2014
81
0.030
 Why?
Drug Therapy, Combination
1
2014
426
0.030
 Why?
Weight Gain
1
2014
244
0.030
 Why?
Microbial Sensitivity Tests
1
2014
290
0.030
 Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
 Why?
Antibodies, Anti-Idiotypic
1
2012
30
0.030
 Why?
Molecular Diagnostic Techniques
1
2013
40
0.030
 Why?
Water
1
2012
103
0.030
 Why?
Disease Progression
1
2014
915
0.030
 Why?
Comorbidity
1
2014
664
0.030
 Why?
Socioeconomic Factors
1
2012
639
0.020
 Why?
Follow-Up Studies
1
2014
2390
0.020
 Why?
Treatment Outcome
1
2014
5612
0.010
 Why?
Child
1
2012
7368
0.010
 Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (204) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department